| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Revenue | $27.4B | $24.9B | $23.2B | $20.8B | $19.6B | $17.9B | $21.4B | $21.6B |
| Cost of Revenue | $17.1B | $15.4B | $14.8B | $13.9B | $13.3B | $12.4B | $14.3B | $14.5B |
| Gross Profit | — | — | — | — | — | — | — | — |
| R&D Expense | $0.8B | $0.8B | $0.8B | $0.7B | $0.6B | $0.6B | $0.6B | $0.6B |
| SG&A Expense | $4.3B | $4.1B | $3.8B | $3.2B | $3.3B | $3.1B | $3.6B | $3.5B |
| Operating Income | — | — | — | — | — | — | $3.7B | $3.6B |
| Net Income | $4.1B | $3.8B | $3.2B | $2.5B | $2.1B | $1.4B | $2.2B | $2.1B |
| EPS (Basic) | $10.48 | $9.54 | $8.06 | $6.17 | $5.38 | $3.51 | $5.28 | $4.93 |
| EPS (Diluted) | $10.45 | $9.50 | $8.02 | $6.14 | $5.34 | $3.49 | $5.25 | $4.91 |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $41.3B | $38.4B | $38.4B | $35.0B | $34.0B | $31.8B | $32.8B | $31.1B |
| Current Assets | $12.4B | $11.8B | $11.7B | $8.7B | $7.5B | $9.2B | $8.7B | $7.6B |
| Cash & Equivalents | $0.6B | $0.6B | $0.5B | $0.3B | $0.3B | $0.4B | $0.4B | $0.3B |
| Total Liabilities | — | — | — | — | — | — | — | — |
| Current Liabilities | $9.4B | $7.9B | $7.7B | $6.4B | $7.2B | $5.9B | $5.1B | $5.2B |
| Stockholders' Equity | $19.4B | $18.5B | $19.0B | $17.0B | $16.4B | $14.9B | $16.1B | $16.1B |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $4.5B | $4.3B | $3.6B | $2.5B | $2.2B | $2.9B | $3.5B | $2.7B |
| Investing Cash Flow | $-1.1B | $-0.3B | $-2.6B | $-1.2B | $-1.8B | $0.4B | $-1.9B | $-0.4B |
| Capital Expenditures | $0.9B | $0.8B | $0.8B | $0.6B | $0.6B | $0.4B | $0.6B | $0.6B |
| Financing Cash Flow | $-3.2B | $-3.9B | $-0.9B | $-1.3B | $-0.5B | $-3.3B | $-1.5B | $-2.6B |